Abstract
Transforming Growth Factor alpha (TGF-α) is a protein structurally similar to Epidermal Growth Factor (EGF) and a ligand for EGF-receptors, competing with Epidermal Growth Factors. It has been found in a variety of non-neoplastic and neoplastic disorders where angiogenesis is involved or contributes to part of the pathology. TGF-β signaling pathway is involved in many cellular processes in the developing embryo. TGF-α is involved in various corneal diseases and is responsible for the angiogenesis and epidermal hyperplasia in psoriasis and has influence in protection and healing of gastro-intestinal lesions. TGF-β is a potent inducer or inhibitor of angiogenesis by increasing pro-angiogenic growth factors such as VEGFs or by enhancing anti-angiogenic factor productions. It has been found in focal ischemia in stroke and in Alzheimer’s disease with attenuation of beta-amyloid (Aβ), TGF-β has shown potential neuroprotective role in reducing accumulation of Aβ deposition indirectly via angiogenesis. TGF- α overexpression has been detected in oesophageal squamous cell carcinoma and is linked to invasive breast carcinoma. TGF-β promotes the formation of tumor microenvironment by interacting with other growth factors (PDGFs, FGFs and VEGFs) and extracellular matrix (ECM) remodeling and its regulatory role in hepatocyte carcinogenesis has been reported recently. The mediatory role of transforming growth factors in angiogenic signaling pathway in tumor progression or anti-tumor angiogenesis is an emerging therapeutic target.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Attisano L, Carcamo J, Ventura F, Weis FMB, Massague J, Wrana JL (1993) Identification of human activin and TGFP Type I receptors that form heteromeric kinase complexes with Type II receptors. Cell 75:9
Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, Burchfield J, Fox H, Doebele C, Ohtani K, Chavakis E, Potente M, Tjwa M, Urbich C, Zeiher AM, Dimmeler S (2009) MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324(5935):1710–1713. doi:10.1126/science.1174381
Cabrijan L, Lipozencic J, Batinac T, Lenkovic M, Zgombic ZS (2013) Differences between keratoacanthoma and squamous cell carcinoma using TGF-alpha. Coll Antropol 37(1):147–150
Caraci F, Battaglia G, Bruno V, Bosco P, Carbonaro V, Giuffrida ML, Drago F, Sortino MA, Nicoletti F, Copani A (2011) TGF-beta1 pathway as a new target for neuroprotection in Alzheimer’s disease. CNS Neurosci Ther 17:237–249
Caraci F, Spampinato S, Sortino MA, Bosco P, Battaglia G, Bruno V, Drago F, Nicoletti F, Copani A (2012) Dysfunction of TGF-beta1 signaling in Alzheimer’s disease: perspectives of neuroprotection. Cell Tissue Res 347:291–301
Chen J, Venkat P, Zacharek A, Chopp M (2014) Neurorestorative therapy for stroke. Front Hum Neurosci 8:382. doi:10.3389/fnhum.2014.00382
Christoforidis GA, Mohammad Y, Kehagias D, Avutu B, Slivka AP (2005) Angiographic assessment of pial collaterals as a prognostic indicator following intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 26:1789–1797
Ciardiello F, Kim N, McGeady ML, Liscia DS, Saeki T, Bianco C, Salomon DS (1991) Expression of transforming growth factor alpha (TGF alpha) in breast cancer. Ann Oncol 2(3):169–182
de Groot RP, Kruijer W (1990) Transcriptional activation by TGF beta 1 mediated by the dyad symmetry element (DSE) and the TPA responsive element (TRE). Biochem Biophys Res Commun 168(3):1074–1081
Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E, Furth EE, Lee WM, Enders GH, Mendell JT, Thomas-Tikhonenko A (2006) Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 38(9):1060–1065. doi:10.1038/ng1855
Dobolyi A, Vincze C, Pal G, Lovas G (2012) The neuroprotective functions of transforming growth factor Beta proteins. Int J Mol Sci 13(7):8219–8258. doi:10.3390/ijms13078219
Doyle KP, Cekanaviciute E, Mamer LE, Buckwalter MS (2010) TGFbeta signaling in the brain increases with aging and signals to astrocytes and innate immune cells in the weeks after stroke. J Neuroinflammation 7:62. doi:10.1186/1742-2094-7-62
Elder JT, Fisher GJ, Lindquist PB, Bennett GL, Pittelkow MR, Coffey RJ Jr, Ellingsworth L, Derynck R, Voorhees JJ (1989) Overexpression of transforming growth factor alpha in psoriatic epidermis. Science (New York) 243(4892):811–814
Ferrari G, Cook BD, Terushkin V, Pintucci G, Mignatti P (2009) Transforming growth factor-beta 1 (TGF-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis. J Cell Physiol 219(2):449–458. doi:10.1002/jcp.21706
Fierlbeck W, Liu A, Coyle R, Ballermann BJ (2003) Endothelial cell apoptosis during glomerular capillary lumen formation in vivo. J Am Soc Nephrol 14(5):1349–1354
Filipe MI, Osborn M, Linehan J, Sanidas E, Brito MJ, Jankowski J (1995) Expression of transforming growth factor alpha, epidermal growth factor receptor and epidermal growth factor in precursor lesions to gastric carcinoma. Br J Cancer 71(1):30–36
Geng L, Chaudhuri A, Talmon G, Wisecarver JL, Wang J (2013) TGF-Beta suppresses VEGFA-mediated angiogenesis in colon cancer metastasis. PLoS One 8(3):e59918. doi:10.1371/journal.pone.0059918
Issa R, AlQteishat A, Mitsios N, Saka M, Krupinski J, Tarkowski E, Gaffney J, Slevin M, Kumar S, Kumar P (2005) Expression of basic fibroblast growth factor mRNA and protein in the human brain following ischaemic stroke. Angiogenesis 8(1):53–62. doi:10.1007/s10456-005-5613-8
Jiang F, Mu J, Wang X, Ye X, Si L, Ning S, Li Z, Li Y (2014a) The repressive effect of miR-148a on TGF beta-SMADs signal pathway is involved in the glabridin-induced inhibition of the cancer stem cells-like properties in hepatocellular carcinoma cells. PLoS One 9(5):e96698. doi:10.1371/journal.pone.0096698
Jiang F, Wang X, Liu Q, Shen J, Li Z, Li Y, Zhang J (2014b) Inhibition of TGF-beta/SMAD3/NF-kappaB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells. Toxicol Lett 231:55–61. doi:10.1016/j.toxlet.2014.08.024
Konturek PC, Konturek SJ, Brzozowski T, Ernst H (1995) Epidermal growth factor and transforming growth factor-alpha: role in protection and healing of gastric mucosal lesions. Eur J Gastroenterol Hepatol 7(10):933–937
Li Z, Shimada Y, Uchida S, Maeda M, Kawabe A, Mori A, Itami A, Kano M, Watanabe G, Imamura M (2000) TGF-alpha as well as VEGF, PD-ECGF and bFGF contribute to angiogenesis of esophageal squamous cell carcinoma. Int J Oncol 17(3):453–460
Li JH, Zhu HJ, Huang XR, Lai KN, Johnson RJ, Lan HY (2002) Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation. J Am Soc Nephrol 13(6):1464–1472
Magloire H, Romeas A, Melin M, Couble ML, Bleicher F, Farges JC (2001) Molecular regulation of odontoblast activity under dentin injury. Adv Dent Res 15:46–50
Melin M, Joffre-Romeas A, Farges JC, Couble ML, Magloire H, Bleicher F (2000) Effects of TGFbeta1 on dental pulp cells in cultured human tooth slices. J Dent Res 79(9):1689–1696
Mirzoeva S, Kim ND, Chiu K, Franzen CA, Bergan RC, Pelling JC (2008) Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells. Mol Carcinog 47(9):686–700. doi:10.1002/mc.20421
Mirzoeva S, Franzen CA, Pelling JC (2014) Apigenin inhibits TGF-beta-induced VEGF expression in human prostate carcinoma cells via a Smad2/3- and Src-dependent mechanism. Mol Carcinog 53(8):598–609. doi:10.1002/mc.22005
Nakagawa T, Li JH, Garcia G, Mu W, Piek E, Bottinger EP, Chen Y, Zhu HJ, Kang DH, Schreiner GF, Lan HY, Johnson RJ (2004) TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways. Kidney Int 66(2):605–613. doi:10.1111/j.1523-1755.2004.00780.x
Nakashima M, Toyono T, Murakami T, Akamine A (1998) Transforming growth factor-beta superfamily members expressed in rat incisor pulp. Arch Oral Biol 43(9):745–751
Navaratna D, Guo S, Arai K, Lo EH (2009) Mechanisms and targets for angiogenic therapy after stroke. Cell Adh Migr 3(2):216–223
Otten J, Bokemeyer C, Fiedler W (2010) Tgf-Beta superfamily receptors-targets for antiangiogenic therapy? J Oncol 2010:317068. doi:10.1155/2010/317068
Piattelli A, Rubini C, Fioroni M, Tripodi D, Strocchi R (2004) Transforming growth factor-beta 1 (TGF-beta 1) expression in normal healthy pulps and in those with irreversible pulpitis. Int Endod J 37(2):114–119
Piek E, Ju WJ, Heyer J, Escalante-Alcalde D, Stewart CL, Weinstein M, Deng C, Kucherlapati R, Bottinger EP, Roberts AB (2001) Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts. J Biol Chem 276(23):19945–19953. doi:10.1074/jbc.M102382200
Prime SS, Pring M, Davies M, Paterson IC (2004) TGF-beta signal transduction in oro-facial health and non-malignant disease (part I). Crit Rev Oral Biol Med 15(6):324–336
Seystahl K, Tritschler I, Szabo E, Tabatabai G, Weller M (2015) Differential regulation of TGF-beta-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma. Neuro Oncol 17:254–265. doi:10.1093/neuonc/nou218
Smith AJ, Matthews JB, Hall RC (1998) Transforming growth factor-beta1 (TGF-beta1) in dentine matrix. Ligand activation and receptor expression. Eur J Oral Sci 106(Suppl 1):179–184
Soares R, Pereira MB, Silva C, Amendoeira I, Wagner R, Ferro J, Schmitt FC (2000) Expression of TGF-alpha and EGFR in breast cancer and its relation to angiogenesis. Breast J 6(3):171–177
Sporn MB, Roberts AB, Wakefield LM, Assoian RK (1986) Transforming growth factor-B biological function and chemical structure. Science 233:2
Tesseur I, Zou K, Esposito L, Bard F, Berber E, Can JV, Lin AH, Crews L, Tremblay P, Mathews P (2006) Deficiency in neuronal TGF-beta signaling promotes neurodegenration and Alzheimer’s pathology. J Clin Invest 116:3060–3069
Wang B, Hsu SH, Majumder S, Kutay H, Huang W, Jacob ST, Ghoshal K (2010) TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene 29(12):1787–1797. doi:10.1038/onc.2009.468
Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang X-F, Massague J (1992) TGFβ signals through a heteromeric protein kinase receptor complex. Cell 71:11
Yang SY, Miah A, Pabari A, Winslet M (2011) Growth factors and their receptors in cancer metastases. Front Biosci (Landmark Ed) 16:531–538
Zhou F, Xiang Z, Peiling L, Junjie J, Zhen LX (2001) The expression and changes of heat shock protein 70, MDA and haemorheology in rat cortex after diffuse axonal injury with secondary insults. J Clin Neurosci 8(3):250–252. doi:10.1054/jocn.2000.0760
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Salajegheh, A. (2016). Transforming Growth Factor α and β (TGF-α and TGF-β). In: Angiogenesis in Health, Disease and Malignancy. Springer, Cham. https://doi.org/10.1007/978-3-319-28140-7_53
Download citation
DOI: https://doi.org/10.1007/978-3-319-28140-7_53
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-28138-4
Online ISBN: 978-3-319-28140-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)